Evidence map›Paper›PMID 42352008›Full record

ArticleAntioxidants (Basel, Switzerland)2026

Covalent Modification of Keap1 by the Key Metabolic Cofactor Coenzyme A Under Oxidative and Metabolic Stress.

Xuezhe Zhou, Oksana Malanchuk, Dejun Zhang, Alexander Zhyvoloup, Maria-Armineh Tossounian, Takafumi Suzuki, Masayuki Yamamoto, Valeriy Filonenko, Jerome Gouge, Ivan Gout

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xuezhe ZhouDepartment of Structural and Molecular Biology, University College London, London WC1E 6BT, UK.
Oksana MalanchukDepartment of Structural and Molecular Biology, University College London, London WC1E 6BT, UK.
Dejun ZhangDepartment of Structural and Molecular Biology, University College London, London WC1E 6BT, UK.
Alexander ZhyvoloupDepartment of Structural and Molecular Biology, University College London, London WC1E 6BT, UK.
Maria-Armineh TossounianDepartment of Structural and Molecular Biology, University College London, London WC1E 6BT, UK.ORCID 0000-0003-3679-7376
Takafumi SuzukiDepartment of Medical Biochemistry, Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan.ORCID 0000-0002-3425-8208
Masayuki YamamotoDepartment of Medical Biochemistry, Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan.
Valeriy FilonenkoDepartment of Cell Signalling, Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, 03680 Kyiv, Ukraine.
Jerome GougeDepartment of Structural and Molecular Biology, University College London, London WC1E 6BT, UK.
Ivan GoutDepartment of Structural and Molecular Biology, University College London, London WC1E 6BT, UK.ORCID 0000-0001-9179-8393

Funding

Biotechnology and Biological Sciences Research Council BB/L010410/1Biotechnology and Biological Sciences Research Council BB/S009027/1
6 · The paper itself

Abstract

Kelch-like ECH-associated protein 1 (Keap1) acts as a repressor of nuclear factor-erythroid 2-related factor 2 (Nrf2), a major transcription factor regulating cellular antioxidant response. Keap1 is the substrate adaptor subunit of the cullin 3-RING E3 ubiquitin ligase complex that specifically facilitates Nrf2 ubiquitination and its proteasomal degradation. Keap1 is rich in cysteine residues, and several of them undergo various modifications, such as sulphydration, nitrosylation and glutathionylation under cellular stress conditions. Some of these modifications alter the conformation of Keap1, preventing Nrf2 from ubiquitination and subsequent proteasome-mediated degradation. As a result, newly synthesised Nrf2 translocates to the nucleus to induce the expression of diverse genes involved in protecting cells against oxidative stress. Protein CoAlation is a reversible redox-dependent post-translational modification (PTM) in which coenzyme A (CoA) forms disulphide bonds with oxidised cysteine residues under oxidative or metabolic stress. In this study, we demonstrate for the first time that disulphide Keap1 dimer undergoes CoAlation in cellular response to oxidative stress induced by various oxidising compounds. Furthermore, glucose deprivation also induces CoAlation of the disulphide Keap1 dimer in HEK293/Pank1β cells. We also demonstrate that the Keap1

Indexed as

antioxidant responseCoAlationcoenzyme AKeap1/Nrf2post-translational modification

Identifiers

PMID42352008
PMCPMC13295608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.